The Pennine Acute Hospitals NHS Trust Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • The Pennine Acute Hospitals NHS Trust's estimated annual revenue is currently $521.3M per year.(i)
  • The Pennine Acute Hospitals NHS Trust's estimated revenue per employee is $378,000

Employee Data

  • The Pennine Acute Hospitals NHS Trust has 1379 Employees.(i)
  • The Pennine Acute Hospitals NHS Trust grew their employee count by -6% last year.

The Pennine Acute Hospitals NHS Trust's People

NameTitleEmail/Phone
1
Chief OfficerReveal Email/Phone
2
Deputy Chief Delivery OfficerReveal Email/Phone
3
Logistics OfficerReveal Email/Phone
4
Senior Clinical Coding OfficerReveal Email/Phone
5
Emergency Planning OfficerReveal Email/Phone
6
Pharmacy Assistant Technical OfficerReveal Email/Phone
7
estates officer BuildingReveal Email/Phone
8
Clerical OfficerReveal Email/Phone
9
Field Technical Support OfficerReveal Email/Phone
10
EPR Training & Implementation OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.8M50-4%N/AN/A
#2
$42.8M1445%N/AN/A
#3
$10.8M50-26%N/AN/A
#4
$54.6M1843%N/AN/A
#5
$62.4M2106%N/AN/A
#6
$27.8M10311%N/AN/A
#7
$6.9M32-20%N/AN/A
#8
$268.4M7102%N/AN/A
#9
$102.3M3035%N/AN/A
#10
$15.3M63-32%N/AN/A
Add Company

What Is The Pennine Acute Hospitals NHS Trust?

The Pennine Acute Hospitals Trust serves the communities of Bury, Rochdale and Oldham, along with the surrounding towns and villages.

keywords:N/A

N/A

Total Funding

1379

Number of Employees

$521.3M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

The Pennine Acute Hospitals NHS Trust News

2022-04-06 - Royal Oldham Hospital trust staff lay bare pressure in NHS Survey

Of the survey respondents at the Pennine Acute Hospitals Trust, just 21 per cent said there were enough staff at their organisation for them to...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$649.3M14149%N/A
#2
$289.9M1428-1%N/A
#3
$470M147910%N/A
#4
$670.1M14917%N/A
#5
$372.2M15195%N/A